Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients
The prolongation of the QT interval represents the main feature of the long QT syndrome (LQTS), a life-threatening genetic disease. The heterozygous SCN5A V411M mutation of the human sodium channel leads to a LQTS type 3 with severe proarrhythmic effects due to an increase in the late component of t...
Saved in:
Main Authors: | Jordi Cano (Author), Esther Zorio (Author), Andrea Mazzanti (Author), Miguel Ángel Arnau (Author), Beatriz Trenor (Author), Silvia G. Priori (Author), Javier Saiz (Author), Lucia Romero (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early Repolarization is Associated with Short QT Syndrome in Italian Cohort
by: E. Rawick, et al.
Published: (2017) -
RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015) -
RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015) -
Flecainide intoxication in pediatric patients with supraventricular tachycardia
by: Guiem Vaquer, et al.
Published: (2020) -
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: James A. Coleman, et al.
Published: (2024)